CTLA4 and neoplasm: Cytotoxic T lymphocyte-associated protein-4 (CTLA-4) has been found able to bind to TEX cells and blocking CTLA-4 with antibodies has been shown to enhance the anti-tumour immune response in mouse preclinical models [46].